Clinical experience of K18 (IgG-melphalan) for five cases of refractory multiple myeloma.
Kanamaru
R
R
Wakui
A
A
Ishioka
C
C
Okuno
M
M
Konishi
Y
Y
Ishikawa
A
A
Shibata
H
H
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage; D000922:Immunotoxins / Q000627:therapeutic use*; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage
D007074:Immunoglobulin G; D000922:Immunotoxins; D011239:Prednisolone; D008558:Melphalan